FDA Inspection 1302596 — Catalyst Clinical Research
The FDA completed an inspection of Catalyst Clinical Research on Jan 16, 2026 in Wilmington, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 16, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Wilmington, NC (United States)
Additional details
Sponsor, Contract Research Organization